TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis

Xiaodan Xu; Lu Zhang; Xiaogang He; Ping Zhang; Caihong Sun; Xiaojun Xu; Yaojuan Lu; Feifei Li

doi:10.1016/j.bbrc.2018.05.139

journal article Jul 01, 2018

TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis

Xiaodan Xu

Lu Zhang

Xiaogang He

Ping Zhang

Caihong Sun Xiaojun Xu

Yaojuan Lu Feifei Li

Biochemical and Biophysical Research Communications Vol. 502 No. 1 pp. 160-165 · Elsevier BV

View at Publisher Save 10.1016/j.bbrc.2018.05.139

Topics

No keywords indexed for this article. Browse by subject →

References

27

[1]

Siegel "Cancer statistics, 2018" CA A Cancer J. Clin. (2018) 10.3322/caac.21442

[2]

Koboldt "Comprehensive molecular portraits of human breast tumours" Nature (2012) 10.1038/nature11412

[3]

Nielsen "Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma" Clin. Canc. Res.: Offic. J. Am. Assoc. Canc. Res. (2004) 10.1158/1078-0432.ccr-04-0220

[4]

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini, Justin M. Balko, Ingrid A. Mayer et al.

Nature Reviews Clinical Oncology 2016 10.1038/nrclinonc.2016.66

[5]

Forrest "The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts" Canc. Chemother. Pharmacol. (2013) 10.1007/s00280-012-2049-x

[6]

Valent "Cancer stem cell definitions and terminology: the devil is in the details" Nat. Rev. Canc. (2012) 10.1038/nrc3368

[7]

Al-Hajj "Prospective identification of tumorigenic breast cancer cells" Proc. Natl. Acad. Sci. U.S.A. (2003) 10.1073/pnas.0530291100

[8]

Charafe-Jauffret "ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program" Canc. Res. (2013) 10.1158/0008-5472.can-12-4704

[9]

Principe "TGF-β: duality of function between tumor prevention and carcinogenesis" JNCI Journal of the National Cancer Institute (2014) 10.1093/jnci/djt369

[10]

Jung (2017)

[11]

Johnson "In vitro tumorsphere formation assays" Bio-protocol (2013) 10.21769/bioprotoc.325

[12]

Liu "A comprehensive immunologic portrait of triple-negative breast cancer" Translational Oncology (2018) 10.1016/j.tranon.2018.01.011

[13]

Funamizu "Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma" Int. J. Canc. (2013) 10.1002/ijc.27736

[14]

Hardee "Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-beta" Canc. Res. (2012) 10.1158/0008-5472.can-12-0546

[15]

Kajiyama "Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells" Int. J. Oncol. (2007)

[16]

Singh "EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer" Oncogene (2010) 10.1038/onc.2010.215

[17]

Mallini "Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance" Canc. Treat Rev. (2014) 10.1016/j.ctrv.2013.09.008

[18]

Liu "Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-beta1/STAT3 axis-regulated EMT" Cell Death & Disease (2017) 10.1038/cddis.2017.417

[19]

Wang "Suppression of TGF-beta1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins" Artificial cells, nanomedicine, and biotechnology (2017) 10.1080/21691401.2017.1389748

[20]

Pu "Aberrant TGF-beta signaling drives castration-resistant prostate cancer in a male mouse model of prostate tumorigenesis" Endocrinology (2017) 10.1210/en.2017-00086

[21]

Oshimori "TGF-beta promotes heterogeneity and drug resistance in squamous cell carcinoma" Cell (2015) 10.1016/j.cell.2015.01.043

[22]

Hesler "TGF-beta-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3" Carcinogenesis (2016) 10.1093/carcin/bgw093

[23]

Zhuang "TGFbeta1 promotes gemcitabine resistance through regulating the LncRNA-LET/NF90/miR-145 signaling Axis in bladder cancer" Theranostics (2017) 10.7150/thno.19542

[24]

Kakarala "Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy" J. Clin. Oncol. : Offic. J. Am. Soc. Clin. Oncol. (2008) 10.1200/jco.2008.16.3931

[25]

Jong "Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression" Biochem. Biophys. Res. Commun. (2002) 10.1006/bbrc.2002.6666

[26]

Ewen "TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest" Cell (1993) 10.1016/0092-8674(93)90723-4

[27]

Patel "Transforming growth factor-beta 1 signaling regulates neuroinflammation and apoptosis in mild traumatic brain injury" Brain Behav. Immun. (2017) 10.1016/j.bbi.2017.04.012

Cited By

147

TGF-β in tumor development and progression: mechanisms and therapeutics

Yiwei Wang, Chao Tang · 2026

Molecular Biomedicine

Inflammation-associated drug resistance and tumor growth in TNBC

Arij Fouzat Hassan, Hadeel Kheraldine · 2025

Frontiers in Immunology

Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies

Khansa Sheikh, Momna Amjad · 2025

OncoTargets and Therapy

Drug resistance in breast cancer: Mechanisms and strategies for management

Guo-Yu Wu, Ming-Zhu Xiao · 2025

Drug Resistance Updates

Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway

Kumar Ganesan, Cong XU · 2024

Science China Life Sciences

Basal–epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer

Mohammed Inayatullah, Arun Mahesh · 2024

EMBO Molecular Medicine

Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications

Alejandro Ordaz-Ramos, Olivia Tellez-Jimenez · 2023

Frontiers in Cell and Developmental...

Recent advances in targeted strategies for triple-negative breast cancer

Shuangli Zhu, Yuze Wu · 2023

Journal of Hematology & Oncolog...

TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation

Bikash Chandra Jena, Chandan Kanta Das · 2022

Experimental Cell Research

ICAM1 promotes bone metastasis via integrin‐mediated TGF‐β/EMT signaling in triple‐negative breast cancer

Mingcang Chen, Chunyu Wu · 2022

Cancer Science

Metrics

147

Citations

27

References

Details

Published: Jul 01, 2018
Vol/Issue: 502(1)
Pages: 160-165
License: View

Authors

Xiangtan University

Funding

Anhui Colleges and Universities Natural Science Foundation Award: KJ2018ZD018

Anhui Medical University Excellent Youth Training Program Award: GJYQ-1403

Cite This Article

Xiaodan Xu, Lu Zhang, Xiaogang He, et al. (2018). TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis. Biochemical and Biophysical Research Communications, 502(1), 160-165. https://doi.org/10.1016/j.bbrc.2018.05.139

TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis

You May Also Like